
Using a case-based format, Lisa Sammaritano, MD, and other panelists will demonstrate how to use the guideline in a clinical setting, highlighting updates for 2025, and describe how the new recommendations were developed.
Panelists, including Jin Kyun Park, MD, will discuss vaccine response in immunocompromised patients and vaccines as preventative care for those patients.
Jose U. Scher, MD, will discuss challenges associated with addressing early onset psoriatic arthritis (PsA). The session also will review therapies for managing PsA.
Presentations in this Sunday session will include an assessment of the latest advances in better understanding the multiple phenotypes of pulmonary sarcoidosis from Michelle Sharp, MD, MHS.
Guideline authors, including R. Hal Scofield, MD, will review the practical implications of the guidelines for care of patients and discuss specific case presentations. The guidelines stress the need for a multidisciplinary approach to manage Sjögren’s-related neuropathy effectively.
Private practice rheumatologists, including Saimun Singla, DO, FACR, will explain how they successfully implemented the direct care model and how it has affected their job satisfaction and patient care.
Osteoarthritis (OA) researcher Richard F. Loeser, Jr., MD, MACR, will explain the fundamental science underlying OA pathogenesis and the potential therapeutic interventions for the disease.
A Sunday morning session will delve into the dynamics of how microbial and host byproducts drive inflammation. One of the featured speakers, Renuka Nayak, MD, PhD, will discuss therapeutic approaches to treat rheumatoid arthritis using short-chain fatty acids.
Experts, including Kim M. Huffman, MD, PhD, will highlight how this approach to physical activity affects cardiovascular health, physical function, and immune response.
Speakers, including Diana Girnita, MD, PhD, will share what they have learned about making a private rheumatology practice stand out from the crowd and building trust among patients and prospective patients.